Clinical trials sponsored by AHS Cancer Control Alberta

Phase breakdown

Conditions studied

Recruiting trials led by AHS Cancer Control Alberta

• Durvalumab and Tremelimumab in Combination With Propranolol and Chemotherapy for Treatment of Advanced Hepatopancreabiliary Tumors (BLOCKED)
  NCT05451043 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Prophylactic Mesalamine to Prevent Colitis Following Treatment With Ipilimumab/Nivolumab (Ipi/Nivo)
  NCT05663775 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• SBRT of Metastases Following Neo-adjuvant Treatment for Colorectal Cancer With Synchronous Liver Metastases
  NCT05775146 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

How many trials is AHS Cancer Control Alberta recruiting for?

AHS Cancer Control Alberta is the lead sponsor of 3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.